Descripción del proyecto
Diagnóstico sencillo de la endometriosis
La endometriosis es una enfermedad en la que un tejido similar al revestimiento del útero crece fuera de él y afecta a millones de mujeres en edad reproductiva en todo el mundo. El diagnóstico suele consistir un examen pélvico, una ecografía o una resonancia magnética y, en algunos casos, un examen laparoscópico del abdomen. El equipo del proyecto Endosolve, financiado por el Consejo Europeo de Innovación, propone simplificar y mejorar el diagnóstico de la endometriosis mediante la presentación de un biomarcador digital de nuevo desarrollo. La prueba ya ha mostrado resultados prometedores en estudios preclínicos y exploratorios con personas voluntarias, pero es necesario perfeccionarla, validarla en un entorno clínico y desarrollar un modelo de negocio.
Objetivo
Endometriosis is a chronic inflammatory disease defined as the presence of endometrium-like tissue outside the uterus. Establishment and growth of such endometriotic tissue is estrogen-dependent, thus it is mostly found in women of reproductive age. It is estimated that currently at least 190 million women and adolescent girls worldwide are affected by the disease during reproductive age although some women may suffer beyond menopause
She Sense is an accurate and non-invasive test that enables simpler, earlier and more cost-effective diagnosis of patients with endometriosis
Project scope: Experimental proof of principle for the novel digital biomarker has been demonstrated using early generation prototypes for research purposes in a pre-clinical model and exploratory human volunteer study. Sision Medical seeks to mature this technology and validate its use as a clinically acceptable diagnostic test.
Therefore, the scope of this project will focus on the advancement of the She Sense test to investor readiness by;
Further refinement of the signal processing to optimise the digital biomarker performance
Validation of the biomarker in a clinical setting
Development of a sustainable business case and business model towards commercialisation
The end point of the project is the compilation and evaluation of data obtained in a prospective clinical study. EIC funding will enable Sision Medical to enhance the technology efficacy and validation in a clinical setting. This will pave the path for larger studies which will demonstrate clinically acceptable sensitivity and specificity of the She Sense diagnostic test.
Palabras clave
Programa(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Convocatoria de propuestas
HORIZON-EIC-2022-TRANSITION-01
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-EIC - HORIZON EIC GrantsCoordinador
H91CV96 Galway
Irlanda
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.